Syndivia
Fiche plateforme
coordonnées
Email : sk@syndivia.com
Télephone : +33 3 68 85 43 01
Adresse : 650 Boulevard Gonthier d’Andernach, 67400 ILLKIRCH
Site Internet
Type d'activité
R&D
Domaine d'activité
Protein-drug conjugates preparation & analysis
Description
Syndivia is developing a family of antibody-drug conjugates (ADC) based on proprietary and classical payload platforms (conjugation on Cys and Lys). Our proprietary site-specific conjugation methodology and novel release triggers have been elaborated to increase circulation half-life, maintain antibodies' effector functions and target affinities. Targeted cancer therapies, Antibody-Drug Conjugates
Mots clés
Targeted cancer therapies, Antibody-Drug Conjugates
Secteur
Privé
Territoire
Alsace